111° West Capital
VC Fund
Alpine, United States
111° West Capital is an investment fund that invests in high-growth digital health companies.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries 111° West Capital invests in
Stages 111° West Capital invests in
Countries 111° West Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Brooks M.D.
|
|||
Michael Matly M.D.
|
|||
Investment Focus
Industry
- Medical 3 (33%)
- Health Care 3 (33%)
- Software 2 (22%)
- Health Insurance 2 (22%)
- Artificial Intelligence 2 (22%)
Stage
- Series B 4 (44%)
- Series A 2 (22%)
- Series C 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Andrew Brooks M.D.
Co-Founder/Managing Partner
|
Co-Founder/Managing Partner | Total investments: 4 | Find email | |
|
Michael Matly M.D.
Co-Founder and Managing Partner
|
Co-Founder and Managing Partner | Total investments: 5 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Healia Health
|
Healia is a company that provides revolutionizing health insurance for dual-income households, saving employers 85% each registered family. | $14M / Series A / Jul 28, 2026 | |
Canopy Works
|
Canopy is a mission-driven healthtech company dedicated to protecting the frontline workforce. Its flagship product, Canopy Protect, provides hospitals with real-time tools to prevent and de-escalate workplace violence. Since its founding in 2019, Canopy has grown to serve more than 60 health systems, protecting more than 300,000 healthcare workersnationwide and ensuring compliance with safety standards. Canopy was built in partnership with leading health systems and a veteran leadership team with executive experience at Google, Microsoft, and Amazon. Canopy is backed by top-tier Silicon Valley investors committed to building a safer, more resilient healthcare environment. | $22M / Series B / Jan 08, 2026 | |
|
Canopy Works
|
Canopy is a mission-driven healthtech company dedicated to protecting the frontline workforce. Its flagship product, Canopy Protect, provides hospitals with real-time tools to prevent and de-escalate workplace violence. Since its founding in 2019, Canopy has grown to serve more than 60 health systems, protecting more than 300,000 healthcare workersnationwide and ensuring compliance with safety standards. Canopy was built in partnership with leading health systems and a veteran leadership team with executive experience at Google, Microsoft, and Amazon. Canopy is backed by top-tier Silicon Valley investors committed to building a safer, more resilient healthcare environment. | $22M / Series B / Jan 08, 2026 | |
Codoxo
|
Codoxo uses AI technology to re-envision healthcare affordability and effectiveness. Its Forensic AI Platform uses a patented algorithm to identify problems and suspicious behavior earlier than traditional techniques which helps ensure our scarce healthcare dollars go to real patient care. It was founded in 2016 and is based in Atlanta, Georgia. | $35M / Series C / Dec 17, 2025 | |
KODE Health
|
KODE Health is an on-demand medical coding solution for maximum flexibility, quality, and control for systems and Koders alike. KODE is a health-tech company seeking to break the traditional model of medical coding and created the first and only on-demand platform that connects healthcare providers and coders in real time. Its headquarters islocated in Holland, Michigan. | $27M / Series B / Jan 30, 2025 | |
Arine
|
Arine offers a comprehensive medication management platform that identifies and supports individuals at risk of medication-related problems to prevent negative health events. The platform integrates clinical expertise and data analytics to optimize medications and improve health outcomes. | $29M / Series B / Aug 17, 2022 | |
|
Arine
|
Arine offers a comprehensive medication management platform that identifies and supports individuals at risk of medication-related problems to prevent negative health events. The platform integrates clinical expertise and data analytics to optimize medications and improve health outcomes. | $29M / Series B / Aug 17, 2022 | |
|
Codoxo
|
Codoxo uses AI technology to re-envision healthcare affordability and effectiveness. Its Forensic AI Platform uses a patented algorithm to identify problems and suspicious behavior earlier than traditional techniques which helps ensure our scarce healthcare dollars go to real patient care. It was founded in 2016 and is based in Atlanta, Georgia. | $5.2M / Series B / Feb 03, 2022 | |
|
Arine
|
Arine offers a comprehensive medication management platform that identifies and supports individuals at risk of medication-related problems to prevent negative health events. The platform integrates clinical expertise and data analytics to optimize medications and improve health outcomes. | $11M / Series A / Jan 11, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does 111° West Capital invest in?
111° West Capital invests primarily in Medical, Health Care and Software startups, most often at Series B and Series A stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact 111° West Capital?
Public channels for 111° West Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at 111° West Capital?
The team at 111° West Capital includes Andrew Brooks M.D. (Co-Founder/Managing Partner) and Michael Matly M.D. (Co-Founder and Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
